ACRV
Acrivon Therapeutics, Inc.
2.10$
+2.9%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
Acrivon Therapeutics, Inc. (ACRV) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -15 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -9.8 | -12 | -17 | -14 | -17 | -17 | -20 | -17 | -12 | -15 | -21 | -15 | -63 | |
| 0.1 | 0.1 | 0.2 | 0.2 | 0.3 | 0.3 | 0.3 | 0.2 | 0.3 | 0.4 | 0.4 | 0.4 | 1.5 | |
| 3.2 | 3.1 | 3.3 | 3.6 | 3.7 | 3.7 | 3.8 | 3.9 | 3.9 | 3.1 | 2.2 | 2.2 | 11 | |
| 1.8 | 4.2 | -3.8 | 2.0 | 2.2 | 2.1 | -3.8 | 0.1 | 1.5 | -0.1 | -4.5 | -1.1 | -4.2 | |
| 0.0 | 1.2 | 0.8 | 0.1 | 1.0 | 0.8 | 0.1 | 0.5 | 0.9 | 0.2 | 0.0 | 0.1 | 1.2 | |
| 1.5 | 21 | 5.9 | -88 | 16 | 14 | 19 | 19 | 5.9 | 22 | 13 | 15 | 56 | |
| 0.1 | -2.0 | -0.2 | 123 | -1.5 | -0.6 | -0.3 | -0.1 | -0.1 | -0.2 | 0.0 | 7.3 | 6.9 | |
| -8.2 | 6.2 | -11 | 21 | -2.8 | -3.6 | -0.7 | 2.7 | -6.5 | 6.1 | -7.4 | 7.4 | -0.5 | |
| -9.8 | -14 | -18 | -14 | -18 | -18 | -20 | -17 | -13 | -15 | -21 | -15 | -64 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.